296 related articles for article (PubMed ID: 22966533)
1. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.
Ahmad T; Bae H; Rhee I; Chang Y; Jin SU; Hong S
J Nanosci Nanotechnol; 2012 Jul; 12(7):5132-7. PubMed ID: 22966533
[TBL] [Abstract][Full Text] [Related]
2. One pot synthesis of water-dispersible dehydroascorbic acid coated Fe3O4 nanoparticles under atmospheric air: blood cell compatibility and enhanced magnetic resonance imaging.
Gupta H; Paul P; Kumar N; Baxi S; Das DP
J Colloid Interface Sci; 2014 Sep; 430():221-8. PubMed ID: 24956575
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
4. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
5. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
[TBL] [Abstract][Full Text] [Related]
6. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application.
Karamipour Sh; Sadjadi MS; Farhadyar N
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():146-55. PubMed ID: 25879984
[TBL] [Abstract][Full Text] [Related]
7. Silica Coated Iron/Iron Oxide Nanoparticles as a Nano-Platform for T
Mathieu P; Coppel Y; Respaud M; Nguyen QT; Boutry S; Laurent S; Stanicki D; Henoumont C; Novio F; Lorenzo J; Montpeyó D; Amiens C
Molecules; 2019 Dec; 24(24):. PubMed ID: 31861222
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
9. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies.
Iancu SD; Albu C; Chiriac L; Moldovan R; Stefancu A; Moisoiu V; Coman V; Szabo L; Leopold N; Bálint Z
Int J Nanomedicine; 2020; 15():4811-4824. PubMed ID: 32753867
[TBL] [Abstract][Full Text] [Related]
11. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
12. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
13. PVP Surface-protected silica coated iron oxide nanoparticles for MR imaging application.
Kermanian M; Sadighian S; Naghibi M; Khoshkam M
J Biomater Sci Polym Ed; 2021 Jul; 32(10):1356-1369. PubMed ID: 33882784
[TBL] [Abstract][Full Text] [Related]
14. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
15. The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study.
Khalkhali M; Rostamizadeh K; Sadighian S; Khoeini F; Naghibi M; Hamidi M
Daru; 2015 Sep; 23(1):45. PubMed ID: 26381740
[TBL] [Abstract][Full Text] [Related]
16. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
17. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
[TBL] [Abstract][Full Text] [Related]
18. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
[TBL] [Abstract][Full Text] [Related]
19. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
20. Highly cross-linked and biocompatible polyphosphazene-coated superparamagnetic Fe3O4 nanoparticles for magnetic resonance imaging.
Hu Y; Meng L; Niu L; Lu Q
Langmuir; 2013 Jul; 29(29):9156-63. PubMed ID: 23795597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
